Bedaquiline-containing regimens for MDR TB treatment - Focus on the safety

被引：0
作者：
Borisov, Sergey
Filippov, Alexsey
Ivanushkina, Taisiya
Ivanova, Diana
Litvinova, Nataliya
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Tuberculosis; -; management; MDR-TB; Treatments;
D O I：
10.1183/13993003.congress-2016.OA3518
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA3518
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006
    Masjedi, M. R.
    Tabarsi, P.
    Chitsaz, E.
    Baghaei, P.
    Mirsaeidi, M.
    Amiri, M. V.
    Farnia, P.
    Javanmard, P.
    Mansouri, D.
    Velayati, A. A.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (07) : 750 - 755
  • [42] Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB
    Rich, ML
    Socci, AR
    Mitnick, CD
    Nardell, EA
    Becerra, MC
    Bonilla, C
    Bayona, J
    Seung, KJ
    Furin, J
    Farmer, PE
    Mukherjee, JS
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (03) : 290 - 296
  • [43] Impact of social support programme on MDR-TB patients' treatment outcomes
    Testov, Vadim
    Sterlikov, Sergey
    Vasilyeva, Irina
    Erokhin, Vladislav
    Kasayeva, Teresa
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [44] Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
    Bonnet, Maryline
    Bastard, Mathieu
    Du Cros, Philipp
    Atadjan, Khamraev
    Kimenye, Kamene
    Khurkhumal, Shazina
    Hayrapetyan, Armen
    Telnov, Alex
    Hewison, Cathy
    Varaine, Francis
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [45] Economic evaluation protocol of a short, all-oral bedaquiline-containing regimen for the treatment of rifampicin-resistant tuberculosis from the STREAM trial
    Rosu, Laura
    Madan, Jason
    Worrall, Eve
    Tomeny, Ewan
    Squire, Bertel
    [J]. BMJ OPEN, 2020, 10 (12):
  • [46] High-dose gatifloxacin-based shorter treatment regimens for MDR/RR-TB
    Nie, Qi
    Tao, Lixuan
    Li, Yingying
    Chen, Nanshan
    Chen, Hua
    Zhou, Yong
    Wang, Yanqiu
    Chen, Huidong
    Tang, Qiuping
    Wang, Xianguang
    Huang, Chaolin
    Yang, Chengfeng
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 115 : 142 - 148
  • [47] Cost-effectiveness of treating MDR-TB by adding delamanid to background regimens in Germany
    Diel, Roland
    Hittel, Norbert
    Schaberg, Tom
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [48] Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial
    Weng, Taoping
    Sun, Feng
    Li, Yang
    Chen, Jiazhen
    Chen, Xinchang
    Li, Rong
    Ge, Shijia
    Zhao, Yanlin
    Zhang, Wenhong
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [49] Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial
    Taoping Weng
    Feng Sun
    Yang Li
    Jiazhen Chen
    Xinchang Chen
    Rong Li
    Shijia Ge
    Yanlin Zhao
    Wenhong Zhang
    [J]. BMC Infectious Diseases, 21
  • [50] Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
    Field, Stephen K.
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 137 - 149
12345